Skip to content

Alamar Biosciences ALMR Service — Revenue

Other product segments

Consumables
$13.96M+178%
Instruments
$7.38M+78.0%

Similar metrics at other companies

LQD
LQDAService — Revenue
$2.98M-4.4%
TEC
TECHService — Revenue
$21.45M-21.3%
NOVA, Inc. logo
NOVService — Revenue
$488.5M-1.9%
NetApp logo
NTAPService — Revenue
$982M+10.7%
AeroVironment logo
AVAVService — Revenue
$130.23M+367%
Nutanix, Inc. logo
NTNXService — Revenue
$338.13M+15.2%

Other financials

Income statement

See full
Revenue$26.0M+98.9%
Gross profit$14.5M+126%
Operating income-$12.3M-44.4%
Net income-$21.3M-178%
EPS (diluted)-$1.74-156%

Balance sheet

See full
Cash & equivalents$64.6M
Total debt$30.6M
Total equity-$178.1M
Total assets$186.5M

Cash flow

See full
Operating cash flow-$20.3M-55.7%
CapEx$600.0K+8.3%
Free cash flow-$20.9M-53.8%

Valuation

See full
Market cap$1.52B
Enterprise value$1.49B

Returns & leverage

See full
Debt / equity-0.2×
Current ratio5.9×

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's service — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alamar Biosciences 's service — revenue?
Alamar Biosciences (ALMR) reported service — revenue of $4.69M in Q1 2026.
What does service — revenue mean?
This metric represents the total revenue generated from providing specialized proteomics services to customers, excluding any pass-through taxes. It captures the income derived from the application of the company's proprietary NULISA technology and Precision Proteomics platform on behalf of third-party clients. This revenue stream reflects the commercial adoption and demand for the company's analytical capabilities as a service offering.